Investor profile
Vesalius Biocapital Partners has backed 9 European tech companies across 10 funding rounds between 2018 and 2025, joining rounds totalling €342M. Most active in Healthtech and Wellness & Beauty. Data as of 7 Aug 2026.
Also recorded as: Vesalius Biocapital
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Caresyntax | Germany | 1 | €164M |
| Memo Therapeutics | Switzerland | 2 | €61M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Topas Therapeutics | Germany | 1 | €22M |
| Oncodna | Belgium |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Caresyntax | Series C | €164M | 2024-08 |
| Memo Therapeutics | Series B | €35M | 2022-02 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Memo Therapeutics |
| 1 |
| €19M |
| OMEICOS | Germany | 1 | €17M |
| Rejuvenate Boimed | Belgium | 1 | €16M |
| Nutrium | Portugal | 1 | €12M |
| tonic app | Portugal | 1 | €3.5M |
| Series C |
| €26M |
| 2023-11 |
| Topas Therapeutics | Series B | €22M | 2020-10 |
| Oncodna | Series B | €19M | 2020-02 |
| OMEICOS | Series C | €17M | 2018-10 |
| Rejuvenate Boimed | Series B | €16M | 2021-10 |
| Nutrium | Series A | €12M | 2025-09 |
| tonic app | Other | €3.5M | 2019-10 |
